Shroufi A, Powles JW: Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins, J Epidemiol Commu- nity Health, 2010; 64: 109-113Shroufi A, Powles JW. Adherence and chemoprevention in major cardiovascular disease: a ...
Faculty Opinions recommendation of Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a ... Auto-GPT is an autonomous agent that leverages recent advancements in adapting Large Language Models (LLMs) for decision-making tasks. While ...
Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on ... To explore the impact of providing additional information about the potential benefits of simvastatin in a patient leaflet on attitudes and ...
The results may in fact underestimate the benefits of simvastatin because on average 17% of placebo allocated patients took a nonstudy statin. The result of this study led to a change in the indications for simvastatin by the FDA, ... A Davalos,M Fisher - 《Stroke》 被引量: 10发表: 200...
All the above further supports the hypothesis of cardiovascular and neurological (polysomnographic parameters) SGLT2i benefits in OSA independently of diabetes [32]. SGLT2is have also been supposed to elicit positive effects in patients with OSA through an intriguing yet controversial effect [70],...
"One of the many ways in which we reduce heart disease is by treating people with statins to lower their cholesterol," Dr. Verma said. "This work brings us closer to understanding whether there is further benefit of newer agents that treat diabetes and whether those benefits persist in people...
Now that the sequencing of the entire genome is a reality, the chore of sorting through human, pathogen, and other organism diversity factors and correlating them with genomic data to provide real pharmaceutical benefits is an active area of research. Comparative genomics is the field of genomics...
Shroufi A, Powles JW: Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins, J Epidemiol Commu- nity Health, 2010; 64: 109-113Shroufi A, Powles JW. Adherence and chemoprevention in major cardiovas- cular disease: a ...
One hundred and twenty-five studies potentially related to the aim of this review were screened, but only 10 were included. The majority of the trials reported additional clinical benefits in the groups that were treated with adjunctive local delivery of statins. Pooled calculations showed that ...
Joo MK, Park JJ, Chun HJ. Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors. Dig Dis. 2018;36(1):1-14.Additional Benefits of Routine Drugs on Gastrointestinal Cancer:Statins,Metformin,and Proton Pump Inhibitors. Joo MK,Park JJ,Chun...